Annual D&A
$95.80 K
+$18.80 K+24.42%
31 December 2022
Summary:
Navidea Biopharmaceuticals annual depreciation & amortization is currently $95.80 thousand, with the most recent change of +$18.80 thousand (+24.42%) on 31 December 2022. During the last 3 years, it has risen by +$25.40 thousand (+36.08%). NAVB annual D&A is now -94.71% below its all-time high of $1.81 million, reached on 31 December 2007.NAVB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$27.00 K
-$100.00-0.37%
30 September 2023
Summary:
Navidea Biopharmaceuticals quarterly depreciation & amortization is currently $27.00 thousand, with the most recent change of -$100.00 (-0.37%) on 30 September 2023. NAVB quarterly D&A is now -98.21% below its all-time high of $1.50 million, reached on 31 December 2007.NAVB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$108.20 K
+$2300.00+2.17%
30 September 2023
Summary:
Navidea Biopharmaceuticals TTM depreciation & amortization is currently $108.20 thousand, with the most recent change of +$2300.00 (+2.17%) on 30 September 2023. NAVB TTM D&A is now -94.03% below its all-time high of $1.81 million, reached on 31 December 2007.NAVB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NAVB Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +36.1% | +49.2% | +45.0% |
| 5 y5 years | -36.3% | -21.3% | -25.4% |
NAVB Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.1% | -2.2% | +49.2% | at high | +45.0% |
| 5 y | 5 years | -36.3% | +36.1% | -26.4% | +75.3% | -25.4% | +53.7% |
| alltime | all time | -94.7% | +113.7% | -98.2% | +108.1% | -94.0% | +115.5% |
Navidea Biopharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2023 | - | $27.00 K(-0.4%) | $108.20 K(+2.2%) |
| June 2023 | - | $27.10 K(-1.8%) | $105.90 K(+5.3%) |
| Mar 2023 | - | $27.60 K(+4.2%) | $100.60 K(+4.9%) |
| Dec 2022 | $95.80 K(+24.4%) | $26.50 K(+7.3%) | $95.90 K(+5.7%) |
| Sept 2022 | - | $24.70 K(+13.3%) | $90.70 K(+7.8%) |
| June 2022 | - | $21.80 K(-4.8%) | $84.10 K(+2.3%) |
| Mar 2022 | - | $22.90 K(+7.5%) | $82.20 K(+6.8%) |
| Dec 2021 | $77.00 K(+9.4%) | $21.30 K(+17.7%) | $77.00 K(+3.2%) |
| Sept 2021 | - | $18.10 K(-9.0%) | $74.60 K(+3.8%) |
| June 2021 | - | $19.90 K(+12.4%) | $71.90 K(+0.8%) |
| Mar 2021 | - | $17.70 K(-6.3%) | $71.30 K(+1.3%) |
| Dec 2020 | $70.40 K(-51.3%) | $18.90 K(+22.7%) | $70.40 K(-20.2%) |
| Sept 2020 | - | $15.40 K(-20.2%) | $88.20 K(-17.6%) |
| June 2020 | - | $19.30 K(+14.9%) | $107.10 K(-14.0%) |
| Mar 2020 | - | $16.80 K(-54.2%) | $124.50 K(-13.8%) |
| Dec 2019 | $144.50 K(-3.9%) | $36.70 K(+7.0%) | $144.50 K(-0.4%) |
| Sept 2019 | - | $34.30 K(-6.5%) | $145.10 K(-2.2%) |
| June 2019 | - | $36.70 K(-0.3%) | $148.40 K(-0.5%) |
| Mar 2019 | - | $36.80 K(-1.3%) | $149.20 K(-0.8%) |
| Dec 2018 | $150.40 K(-40.9%) | $37.30 K(-0.8%) | $150.40 K(-3.3%) |
| Sept 2018 | - | $37.60 K(+0.3%) | $155.60 K(-7.5%) |
| June 2018 | - | $37.50 K(-1.3%) | $168.30 K(-18.3%) |
| Mar 2018 | - | $38.00 K(-10.6%) | $206.00 K(-19.1%) |
| Dec 2017 | $254.60 K(-49.2%) | $42.50 K(-15.5%) | $254.50 K(-23.9%) |
| Sept 2017 | - | $50.30 K(-33.1%) | $334.50 K(-15.5%) |
| June 2017 | - | $75.20 K(-13.1%) | $395.70 K(-9.7%) |
| Mar 2017 | - | $86.50 K(-29.4%) | $438.30 K(-12.6%) |
| Dec 2016 | $501.40 K(-12.3%) | $122.50 K(+9.9%) | $501.40 K(-3.4%) |
| Sept 2016 | - | $111.50 K(-5.3%) | $519.00 K(-3.8%) |
| June 2016 | - | $117.80 K(-21.3%) | $539.70 K(-5.5%) |
| Mar 2016 | - | $149.60 K(+6.8%) | $571.20 K(-0.0%) |
| Dec 2015 | $571.40 K(+14.2%) | $140.10 K(+6.0%) | $571.40 K(+0.1%) |
| Sept 2015 | - | $132.20 K(-11.5%) | $570.80 K(+1.2%) |
| June 2015 | - | $149.30 K(-0.3%) | $563.90 K(+4.7%) |
| Mar 2015 | - | $149.80 K(+7.4%) | $538.70 K(+7.7%) |
| Dec 2014 | $500.20 K(+23.8%) | $139.50 K(+11.3%) | $500.20 K(+12.5%) |
| Sept 2014 | - | $125.30 K(+1.0%) | $444.70 K(+9.8%) |
| June 2014 | - | $124.10 K(+11.5%) | $404.90 K(-7.8%) |
| Mar 2014 | - | $111.30 K(+32.5%) | $439.30 K(+8.7%) |
| Dec 2013 | $404.20 K(+101.9%) | $84.00 K(-1.8%) | $404.10 K(+6.1%) |
| Sept 2013 | - | $85.50 K(-46.1%) | $380.90 K(+9.5%) |
| June 2013 | - | $158.50 K(+108.3%) | $347.70 K(+43.4%) |
| Mar 2013 | - | $76.10 K(+25.2%) | $242.40 K(+21.1%) |
| Dec 2012 | $200.20 K(+13.4%) | $60.80 K(+16.3%) | $200.20 K(+21.3%) |
| Sept 2012 | - | $52.30 K(-1.7%) | $165.10 K(+7.5%) |
| June 2012 | - | $53.20 K(+56.9%) | $153.60 K(+1.9%) |
| Mar 2012 | - | $33.90 K(+31.9%) | $150.80 K(-14.6%) |
| Dec 2011 | $176.50 K(-21.0%) | $25.70 K(-37.0%) | $176.50 K(-16.8%) |
| Sept 2011 | - | $40.80 K(-19.0%) | $212.20 K(-4.1%) |
| June 2011 | - | $50.40 K(-15.4%) | $221.20 K(+0.1%) |
| Mar 2011 | - | $59.60 K(-2.9%) | $221.00 K(-1.1%) |
| Dec 2010 | $223.50 K(-33.0%) | $61.40 K(+23.3%) | $223.40 K(+5.6%) |
| Sept 2010 | - | $49.80 K(-0.8%) | $211.50 K(-12.6%) |
| June 2010 | - | $50.20 K(-19.0%) | $241.90 K(-17.9%) |
| Mar 2010 | - | $62.00 K(+25.3%) | $294.80 K(-11.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $333.70 K(-18.3%) | $49.50 K(-38.3%) | $333.70 K(-14.3%) |
| Sept 2009 | - | $80.20 K(-22.2%) | $389.60 K(+392.5%) |
| June 2009 | - | $103.10 K(+2.2%) | $79.10 K(-80.9%) |
| Mar 2009 | - | $100.90 K(-4.3%) | $413.40 K(+1.2%) |
| Dec 2008 | $408.40 K(-77.4%) | $105.40 K(-145.8%) | $408.30 K(-77.4%) |
| Sept 2008 | - | -$230.30 K(-152.7%) | $1.81 M(+6.0%) |
| June 2008 | - | $437.40 K(+356.6%) | $1.71 M(+7.3%) |
| Mar 2008 | - | $95.80 K(-93.6%) | $1.59 M(-12.2%) |
| Dec 2007 | $1.81 M(+48.3%) | $1.50 M(-552.7%) | $1.81 M(+187.7%) |
| Sept 2007 | - | -$332.40 K(-203.2%) | $629.50 K(-50.6%) |
| June 2007 | - | $322.10 K(+1.8%) | $1.27 M(+2.2%) |
| Mar 2007 | - | $316.50 K(-2.1%) | $1.25 M(+2.1%) |
| Dec 2006 | $1.22 M(-5.5%) | $323.30 K(+3.6%) | $1.22 M(-0.4%) |
| Sept 2006 | - | $312.10 K(+6.0%) | $1.23 M(-1.6%) |
| June 2006 | - | $294.30 K(+1.1%) | $1.25 M(-1.9%) |
| Mar 2006 | - | $291.00 K(-11.4%) | $1.27 M(-1.6%) |
| Dec 2005 | $1.29 M(+50.8%) | $328.30 K(-1.3%) | $1.29 M(+3.8%) |
| Sept 2005 | - | $332.60 K(+4.3%) | $1.24 M(+13.7%) |
| June 2005 | - | $319.00 K(+2.5%) | $1.09 M(+13.8%) |
| Mar 2005 | - | $311.20 K(+10.6%) | $961.60 K(+12.3%) |
| Dec 2004 | $856.00 K(+13.0%) | $281.50 K(+54.2%) | $856.10 K(+19.7%) |
| Sept 2004 | - | $182.50 K(-2.1%) | $715.20 K(-3.0%) |
| June 2004 | - | $186.40 K(-9.4%) | $737.40 K(-1.4%) |
| Mar 2004 | - | $205.70 K(+46.3%) | $747.50 K(-1.4%) |
| Dec 2003 | $757.80 K(-4.9%) | $140.60 K(-31.3%) | $757.80 K(+12.6%) |
| Sept 2003 | - | $204.70 K(+4.2%) | $673.30 K(-10.5%) |
| June 2003 | - | $196.50 K(-9.0%) | $752.60 K(-1.5%) |
| Mar 2003 | - | $216.00 K(+285.0%) | $763.90 K(-4.1%) |
| Dec 2002 | $796.80 K(+88.3%) | $56.10 K(-80.2%) | $796.80 K(-6.2%) |
| Sept 2002 | - | $284.00 K(+36.7%) | $849.70 K(+25.1%) |
| June 2002 | - | $207.80 K(-16.5%) | $679.20 K(+19.4%) |
| Mar 2002 | - | $248.90 K(+128.3%) | $568.80 K(+34.5%) |
| Dec 2001 | $423.10 K(+7.8%) | $109.00 K(-4.0%) | $423.00 K(-40.1%) |
| Sept 2001 | - | $113.50 K(+16.5%) | $706.50 K(+70.6%) |
| June 2001 | - | $97.40 K(-5.5%) | $414.10 K(-16.4%) |
| Mar 2001 | - | $103.10 K(-73.7%) | $495.60 K(+26.3%) |
| Dec 2000 | $392.50 K(-29.0%) | $392.50 K(-319.4%) | $392.50 K(>+9900.0%) |
| Sept 2000 | - | -$178.90 K(-200.0%) | $0.00(-100.0%) |
| June 2000 | - | $178.90 K(-189.5%) | $178.90 K(-125.6%) |
| Dec 1999 | $553.00 K(-56.5%) | - | - |
| Dec 1998 | $1.27 M(+42.0%) | - | - |
| Dec 1997 | $896.50 K(-228.1%) | - | - |
| Dec 1996 | -$700.00 K(+40.0%) | -$200.00 K(0.0%) | -$700.00 K(+16.7%) |
| Sept 1996 | - | -$200.00 K(0.0%) | -$600.00 K(+20.0%) |
| June 1996 | - | -$200.00 K(+100.0%) | -$500.00 K(0.0%) |
| Mar 1996 | - | -$100.00 K(0.0%) | -$500.00 K(0.0%) |
| Dec 1995 | -$500.00 K(-16.7%) | -$100.00 K(0.0%) | -$500.00 K(-16.7%) |
| Sept 1995 | - | -$100.00 K(-50.0%) | -$600.00 K(-14.3%) |
| June 1995 | - | -$200.00 K(+100.0%) | -$700.00 K(+16.7%) |
| Mar 1995 | - | -$100.00 K(-50.0%) | -$600.00 K(0.0%) |
| Dec 1994 | -$600.00 K(+500.0%) | -$200.00 K(0.0%) | -$600.00 K(+50.0%) |
| Sept 1994 | - | -$200.00 K(+100.0%) | -$400.00 K(+100.0%) |
| June 1994 | - | -$100.00 K(0.0%) | -$200.00 K(+100.0%) |
| Mar 1994 | - | -$100.00 K | -$100.00 K |
| Dec 1993 | -$100.00 K(0.0%) | - | - |
| Dec 1992 | -$100.00 K | - | - |
FAQ
- What is Navidea Biopharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Navidea Biopharmaceuticals?
- What is Navidea Biopharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for Navidea Biopharmaceuticals?
What is Navidea Biopharmaceuticals annual depreciation & amortization?
The current annual D&A of NAVB is $95.80 K
What is the all time high annual D&A for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high annual depreciation & amortization is $1.81 M
What is Navidea Biopharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of NAVB is $27.00 K
What is the all time high quarterly D&A for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high quarterly depreciation & amortization is $1.50 M
What is Navidea Biopharmaceuticals TTM depreciation & amortization?
The current TTM D&A of NAVB is $108.20 K
What is the all time high TTM D&A for Navidea Biopharmaceuticals?
Navidea Biopharmaceuticals all-time high TTM depreciation & amortization is $1.81 M